Total Funding
56
38
Total FundingSeed raised
Growth Score
-6 pts
Heat Score
-14 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
145884
ImmuCision Biotherapeutics develops immunotherapy technologies for cancer treatment.
Hua Cheng: Founder and Chief Scientist
About the Company
ImmuCision Biotherapeutics focuses on the research and clinical development of immune cell-based therapies for human cancer. They are the development of cell-based immunotherapy for human cancer. They utilizes an innovative dendritic cell technology to generate cancer-fighting tumor antigen and natural killer cells.
